Cardinal Health (CAH) Cash from Financing Activities (2009 - 2026)
Cardinal Health's (CAH) quarterly Cash from Financing Activities came in at -$483.0 million in Q1 2026, up 5.29% year-on-year from -$458.7 million in Q1 2025, and up 6.94% quarter-over-quarter from -$519.0 million in Q4 2025.
Cardinal Health (CAH) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Cardinal Health has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$483.0 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$483.0 million, up 5.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$449.0 million (down 207.42% YoY), and the FY2025 annual result was $1.9 billion, up 329.04% from the prior year.
- Cash from Financing Activities came in at -$483.0 million for Q1 2026 at Cardinal Health, up from -$519.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $2.3 billion in Q4 2024 to a low of -$1.2 billion in Q3 2022.
- The 5-year median for Cash from Financing Activities is -$483.0 million (2026), against an average of -$225.0 million.
- Across the five-year window, Cash from Financing Activities tumbled 174.71% in 2023 and surged 759.21% in 2024, its largest moves.
- Cardinal Health's Cash from Financing Activities stood at -$362.0 million in 2022, then grew by 2.49% to -$353.0 million in 2023, then soared by 759.21% to $2.3 billion in 2024, then tumbled by 122.3% to -$519.0 million in 2025, then increased by 6.94% to -$483.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$483.0 million (Q1 2026), -$519.0 million (Q4 2025), and -$110.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.82 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.98 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -483.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 120.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 51.08 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 3.80 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 347,627.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -483.00 Mn |
| Mar 31, 2026 | -483.00 Mn |
| Dec 31, 2025 | -519.00 Mn |
| Dec 31, 2025 | -519.00 Mn |
| Sep 30, 2025 | -110.00 Mn |
| Sep 30, 2025 | -110.00 Mn |
| Jun 30, 2025 | 663.00 Mn |
| Jun 30, 2025 | 663.00 Mn |
| Mar 31, 2025 | -510.00 Mn |
| Mar 31, 2025 | -510.00 Mn |
| Dec 31, 2024 | 2.33 Bn |
| Dec 31, 2024 | 2.33 Bn |
| Sep 30, 2024 | -540.00 Mn |
| Sep 30, 2024 | -540.00 Mn |
| Jun 30, 2024 | -859.00 Mn |
| Jun 30, 2024 | -859.00 Mn |
| Mar 31, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.03 Bn |
| Dec 31, 2023 | -353.00 Mn |
| Dec 31, 2023 | -353.00 Mn |